Testosterone therapy for anaemia in maintenance dialysis

Area of Science:

• Nephrology
• Hematology
• Endocrinology

Background:

• Anemia is a common complication in patients undergoing long-term hemodialysis.
• Erythropoiesis-stimulating agents are often used, but alternative treatments are being explored.

Purpose of the Study:

• To evaluate the efficacy of intramuscular testosterone in improving hemoglobin levels in patients on long-term hemodialysis.

Main Methods:

• Twenty-five adult patients on long-term hemodialysis received intramuscular testosterone at a dosage of 250-500 mg weekly.
• Hemoglobin levels were monitored throughout the study period.

Main Results:

• All patients demonstrated a significant increase in hemoglobin levels after testosterone administration.
• The positive effect on hemoglobin was reversible, with levels returning to baseline upon drug discontinuation.
• Treatment efficacy was observed in both nephrectomized and non-nephrectomized patients.

Conclusions:

• Intramuscular testosterone is a safe and effective treatment for anemia in patients on long-term hemodialysis.
• This therapeutic approach can potentially eliminate the need for routine blood transfusions in this patient population.